Durvalumab
CAS: 1428935-60-7
Ref. TM-T11126
1mg | 213.00 € | ||
5mg | 506.00 € | ||
10mg | 727.00 € | ||
25mg | 1,103.00 € | ||
50mg | 1,486.00 € | ||
100mg | 1,990.00 € |
Product Information
- MEDI 4736
Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can block the interaction of PD-L1 with PD-1 and CD80, with IC50 values of 0.1 and 0.04 nM, respectively. Durvalumab is often used in combination with platinum-based compounds for the treatment of non-small cell lung cancer and advanced hepatocellular carcinoma cells.
Chemical properties
Technical inquiry about: TM-T11126 Durvalumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.